WebFeb 1, 2024 · Pfizer remains a highly profitable company, and the valuation of its stock is low. Consider that its forward price-earnings ratio is only 11.25 times. The dividend is also attractive, yielding 4.35%. WebApr 10, 2024 · The firm has a fifty day simple moving average of $41.66 and a 200-day simple moving average of $45.47. The stock has a market capitalization of $234.24 billion, a price-to-earnings ratio of 7.57, a PEG ratio of 1.40 and a beta of 0.64. Pfizer Inc. has a 1-year low of $39.23 and a 1-year high of $56.32. Pfizer ( NYSE:PFE - Get Rating) last ...
Here’s Why Pfizer Stock Looks Inviting At $39 Levels - Forbes
WebStock split history for Johnson & Johnson since 1970. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the . Stock Screener. Stock Research. ... Pfizer (PFE) United States: $235.541B: 6.34: Novartis AG (NVS) Switzerland: $211.746B: WebA Pfizer stock split is no different than any other stock split. Pfizer is simply packaging the number of outstanding shares in a different way. For example, in a 2-for-1 split, the amount of shares will double (and the price will be divided by 2, accordingly). Say you have 100 shares of Pfizer, then the day of the split you will receive 2 ... birmingham city fanzine
Pfizer Is Spinning Off Upjohn. What
WebApr 14, 2024 · Forward-Looking Statements of Pfizer Inc. This transcript may contain forward-looking statements about, among other things, our anticipated operating and financial performance, business plans and prospects; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, … WebApr 12, 2024 · The dividend payout ratio for PFE is: 29.93% based on the trailing year of earnings. 49.70% based on this year's estimates. 43.27% based on next year's estimates. 21.54% based on cash flow. This page (NYSE:PFE) was last updated on 4/10/2024 by MarketBeat.com Staff. Get 30 Days of MarketBeat All Access Free. WebDec 3, 2024 · Pfizer’s stock (NYSE: PFE) is up just 3% since the start of the year and it has gained around 45% from its March lows. Despite the recent rally, Pfizer could offer an upside in the near term, as ... dandridge ii power layflat recliner